On October 28, 2026, IDEX Corporation announced its financial results for the three-month period ended September 30, 2026. The company reported record sales of $952 million, representing an 8% increase on both a reported and organic basis compared to the prior year. Net sales for the quarter were $951.7 million, while orders totaled $991.2 million, an increase of 13%.
GAAP diluted earnings per share (EPS) for the quarter were $1.95, up from $1.70 in the prior year. The company also reported a record adjusted diluted EPS of $2.33, an increase of 15% year-over-year. Gross margin for the period was 45.1%, a 60 basis point improvement over the prior year.
Performance was driven by the Health & Science Technologies segment, which saw net sales increase 14% to $433.5 million. This growth was attributed to higher volumes in data center power and semiconductor markets, as well as strength in space and defense. The Fluid & Metering Technologies segment reported net sales of $327.9 million, up 3%, while the Fire & Safety/Diversified Products segment reported net sales of $191.5 million, up 5%.
IDEX also updated its full-year 2026 guidance. The company now projects full-year organic sales to increase 6.5% to 6.8%, up from the previous guidance of 5% to 6%. Adjusted diluted EPS is now expected to be $8.91 to $8.96, up from the prior range of $8.70 to $8.85.
During the third quarter, IDEX returned $129 million to shareholders through dividends and share repurchases. Additionally, the company amended and restated its $800 million revolving credit facility to extend the maturity date to September 2031.
